TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
Browsing: Bacterial > Tuberculosis
We look at some of the highlights of our Twitter chat (#TalkTB), where we questioned Madhukar Pai, Nandita Venkatesan and Jacob Creswell about all things tuberculosis – from diagnosis to social stigma.
In this infographic we take a look at the diagnostics currently in the pipeline for tuberculosis, highlighting the stage of development and intended use.
Partnership announcements and promising trial data reported at the 2018 Conference on Retroviruses and Opportunistic Infections, take a look at our round-up of the latest industry headlines.
Listen to the top stories in infectious diseases this week, including novel CRISPR-based diagnostics, clinical trial in tuberculosis and the latest CDC approvals for the flu vaccine.
A Phase II trial has suggested potential for new Bacille Calmette–Guerin revaccination strategies in addition to hope for subunit vaccines against tuberculosis.
In a recent study published in Nature Communications, researchers validated a novel screening approach to identify host-directed compounds that reduce the replication of intracellular pathogens, Julie Kaiser explains.
In this infographic we summarize the clinical candidates reported by the WHO – indicating which diseases they are active (or possibly active) against, whether they’re considered innovative and which Phase the trials are currently in.
The WHO’s most recent global tuberculosis report has stated that the burden of TB is still high, with gaps in diagnosis and growing drug-resistance posing challenges on our way to ending this epidemic.